Universe Pharmaceuticals (UPC) Other Accumulated Expenses (2020 - 2026)

Universe Pharmaceuticals has reported Other Accumulated Expenses for 7 years, with the latest figure at $157294.0 in Q1 2026.

• Quarterly Other Accumulated Expenses changed N/A year-over-year to $157294.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $157294.0 (changed N/A YoY) and the FY2025 annual result came in at $446545.0, down 99.99% from the prior year.
• Other Accumulated Expenses declined to $157294.0 in Q1 2026 per UPC's latest filing, from $446545.0 in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $6.9 billion in Q3 2024 and troughed at $7293.0 in Q1 2022.
• A 5-year average of $864.5 million and a median of $2.0 million in 2022 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses jumped 1277558.79% in 2024, then sank 99.99% in 2025.
• Over 5 years, Other Accumulated Expenses stood at $3.4 million in 2022, then tumbled by 84.02% to $540096.0 in 2023, then surged by 1277558.79% to $6.9 billion in 2024, then tumbled by 99.99% to $446545.0 in 2025, then plunged by 64.78% to $157294.0 in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $157294.0, $446545.0, and $6.9 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.